IN THE NEWS
November 3, 2022
Symani Microsurgical Robotic System: Interview with Mark Toland, CEO of Medical Microinstruments
MedGadget
Related News
MMI Earns Gold Edison Award for Symani, Recognized for Expanding Access to Life-Changing Surgical Treatment Options
MMI Earns Gold Edison Award for Symani, Recognized for Expanding Access to Life-Changing Surgical Treatment Options
“First U.S. Patients Treated With Microrobotic Surgery For Alzheimer’s”
“First U.S. Patients Treated With Microrobotic Surgery For Alzheimer’s”
MMI’s Symani Surgical System Treats First Alzheimer’s Patient in Groundbreaking REMIND Study
MMI’s Symani Surgical System Treats First Alzheimer’s Patient in Groundbreaking REMIND Study
MMI Introduces World’s First Microsurgical Suture for Robotics
MMI Introduces World’s First Microsurgical Suture for Robotics
“This Startup Wants To Use Mini Robots To Treat Alzheimer’s”
“This Startup Wants To Use Mini Robots To Treat Alzheimer’s”
New surgical treatment option using robotic microsurgery brings relief to breast cancer survivor with lymphedema
New surgical treatment option using robotic microsurgery brings relief to breast cancer survivor with lymphedema
MMI to Present on Company Momentum and Innovation at 44th Annual J.P. Morgan Healthcare Conference
MMI to Present on Company Momentum and Innovation at 44th Annual J.P. Morgan Healthcare Conference
MMI Wins FDA Clearance and Completes First U.S. Clinical Use of Robotic Microsurgical Dissection Instruments with Symani
MMI Wins FDA Clearance and Completes First U.S. Clinical Use of Robotic Microsurgical Dissection Instruments with Symani
MMI Announces CPT Code and CMS Reimbursement for Robotic Lymphatic Surgery, Unlocking Market Access and Growth Potential
MMI Announces CPT Code and CMS Reimbursement for Robotic Lymphatic Surgery, Unlocking Market Access and Growth Potential
Leading New Jersey hospital treats first patient with new robotic surgical approach to manage symptoms of breast-cancer related lymphedema
Leading New Jersey hospital treats first patient with new robotic surgical approach to manage symptoms of breast-cancer related lymphedema
MMI Receives IDE Approval from FDA for First Robotic Microsurgical Study in Alzheimer’s Patients
MMI Receives IDE Approval from FDA for First Robotic Microsurgical Study in Alzheimer’s Patients
MMI Enrolls First Patient in Landmark U.S. Clinical Study Advancing Robotic Microsurgery
